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Abstract
Introduction: Tropheryma whipplei infection should be considered in patients with suspected infective endocarditis
with negative blood cultures. The case (i) shows how previous symptoms can contribute to the diagnosis of this
illness, and (ii) elucidates current recommended diagnostic and therapeutic approaches to Whipple's disease.
Case presentation: A 71-year-old Swiss man with a past history of 2 years of diffuse arthralgia was admitted for a
possible endocarditis with severe aortic and mitral regurgitation. Serial blood cultures were negative. Our patient
underwent replacement of his aortic and mitral valve by biological prostheses. T. whipplei was documented by
polymerase chain reactions on both removed valves and on stools, as well as by valve histology. A combination of
hydroxychloroquine and doxycycline was initiated as lifetime treatment followed by the complete disappearance of
his arthralgia.
Conclusions: This case report underlines the importance of considering T. whipplei as a possible causal etiology of
blood culture-negative endocarditis. Lifelong antibiotic treatment should be considered for this pathogen (i) due to
the significant rate of relapses, and (ii) to the risk of reinfection with another strain since these patients likely have
some genetic predisposition.
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Introduction
Blood culture-negative endocarditis (BCNE) represents
an important challenge for diagnosis and is therefore as-
sociated with higher morbidity and mortality than blood
culture-positive endocarditis [1]. BCNE is defined as def-
inite or probable endocarditis according to Duke’s cri-
teria with at least three aerobic and anaerobic blood
cultures remaining negative despite prolonged incuba-
tion [1]. BCNE represents about 3 % of all endocarditis
cases. The most common cause is prior administration
of antibiotics followed by fastidious bacteria such as
Coxiella burnetti, Bartonella species and Tropheryma
whipplei. Incidence of BCNE of unexplained etiology is
decreasing thanks to improved diagnostic techniques, in-
cluding eubacterial PCRs, improved culture-based ap-
proaches, as well as species-specific PCRs, serology and
immunohistology [2]. In this case report we describe a
patient with a history of 2 years of migratory joint pain
who presented with dyspnea due to endocarditis finally
attributed to T. whipplei.
Case presentation
A 71-year-old Caucasian man, known as a HLA B27 car-
rier complained of progressive dyspnea for 4 months with-
out any other respiratory or cardiovascular symptom. His
medical history revealed a metabolic syndrome and migra-
tory joint pains for the past 2 years without signs of local
inflammation. Extensive investigations failed to identify a
precise diagnosis and nonsteroidal anti-inflammatory
drugs (NSAIDs) were empirically prescribed. He was not
known for past history of cardiopulmonary disease and
the rest of his past medical history was noncontributory.
On physical examination, systolic and diastolic heart
murmurs were heard at the precordium. An outpatient
transthoracic echocardiography revealed aortic and mi-
tral regurgitation and vegetations of both valves were
suspected. Our patient was admitted to a regional hos-
pital. On admission, he complained of dyspnea at rest
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(New York Heart Association Functional Classification
class IV) and orthopnea and reported a single episode
of fever (38.8 °C) without chills a week before. On clin-
ical examination, our patient presented signs of acute
heart failure with bilateral crackles on pulmonary auscul-
tation, elevated jugular venous pressure and peripheral
edema. Cardiac auscultation revealed a 3/6 decrescendo
diastolic murmur over the aortic and a 2/6 holosystolic
murmur over the mitral region. The routine laboratory
workup was unremarkable with a white blood cell count
of 4.1 g/L, and a C-reactive protein level of 21 mg/L (nor-
mal value <10 mg/L). Four pairs of blood cultures were
drawn, which remained negative. Transesophageal echo-
cardiography showed severe aortic regurgitation due to
left coronary leaflet perforation (Fig. 1a and b), significant
mitral regurgitation due to rupture of the chordae tendi-
neae (Fig. 1c and d), and the presence of vegetations on
both valves (size <15 mm) (Fig. 2a and b). The left ven-
tricle (LV) was hypertrophied and enlarged with mild sys-
tolic dysfunction (LV ejection fraction 53 %). A computed
tomography scan of his brain was negative for distant sep-
tic emboli. Our patient was admitted to the intensive care
unit with the diagnosis of a possible endocarditis with se-
vere bivalvular regurgitation. Empirical antibiotic therapy
was initiated with amoxicillin-clavulanate and gentamicin.
In addition, intravenous furosemide and oxygen were
administered to treat heart failure. As blood cultures
showed no growth after 14 days of incubation including
for HACEK (Haemophilus species, Aggregatibacter spe-
cies, Cardiobacterium hominis, Eikenella corrodens, and
Kingella species) bacteria, a search for fastidious bacteria
by serology and polymerase chain reaction (PCR) was per-
formed. Moreover, the antibiotic spectrum was widened
by the addition of ciprofloxacin and doxycycline.
The patient was transferred to our hospital for further
treatment. Coronary angiography was normal. Our pa-
tient underwent successful replacement of the aortic and
mitral valves by biological prostheses with an uneventful
recovery. Gross examination of the valves revealed mul-
tiple yellowish vegetations on the ventricular side of the
Fig. 1 Transoesophageal echocardiographic views of the aortic and mitral valve. a Visualization of the perforation of aortic cusp (arrow). b Visualization
of the large regurgitant jet through perforated aortic cusp (arrow). c Three-dimensional transoesophageal echocardiography of mitral valve.
d Three-dimensional transoesophageal echocardiography: visualization of regurgitant color Doppler jet through mitral valve (arrows)
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mitral (Fig. 3) and aortic valve. Histology showed conflu-
ent areas of foamy macrophages on hematoxylin and
eosin (Fig. 4a and b), strongly colored by periodic acid-
Schiff (PAS) and Warthin-Starry staining (Fig. 4c and d,
respectively). The rest of the valves showed minor de-
generative changes in the form of light fibrosis, myxoid
stroma and focal calcifications, without neovasculariza-
tion. Both valves were positive for T. whipplei with specific
PCRs adapted from Fennolar et al. with 18,000,000 cop-
ies/mL on the aortic valve [3]. In addition, the same T.
whipplei-specific PCR of the stools was positive with
32,000 copies/mL; however, the T. whipplei PCRs of saliva
and blood returned negative. No upper gastrointestinal
investigations were performed given the absence of symp-
toms. PCR and serology results for Coxiella burnetti and
Bartonella henselae were negative. The antibiotic treat-
ment was switched to ceftriaxone and gentamicin for 2
weeks and then relayed by doxycycline and hydroxychlor-
oquine orally for lifetime.
At his 3-month follow-up, our patient had no cardiac
complaints except a mild dyspnea at exercise. Echocardi-
ography confirmed a good function of both prostheses
without leakage but persistence of a systolic dysfunction
(LV ejection fraction 45 %). Interestingly, our patient re-
ported the complete disappearance of his arthralgia since
the introduction of the antibiotic treatment.
Fig. 2 Transoesophageal echocardiographic views of the aortic and mitral valve. a Visualization of subacute vegetations on posterior leaflet and
chordae tendinae of mitral valve (arrows). b Visualization of a vegetation on aortic valve (arrow)
Fig. 3 Histopathology findings: gross appearance of T. whipplei-infected native mitral valve specimen. a Unremarkable atrial side of valvular leaflet.
b Transverse section of valve harboring voluminous bright yellow vegetations (arrowheads), up to 6 mm exclusively confined to the ventricular
side of the valve and chordae tendinae
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Discussion
Classical Whipple’s disease (cWD) is a late-onset chronic
multisystemic infectious disease caused by T. whipplei
[4, 5]. The transmission of the pathogen is probably re-
lated to the fecal-oral route [6]. The classical clinical
manifestations of cWD are weight loss, diarrhea, abdom-
inal pain and polyarthralgia [5]. The extraintestinal man-
ifestations of cWD are most commonly cardiac and
neurologic, but osteoarticular infections, uveitis, muco-
cutaneous and pulmonary diseases have also been de-
scribed [5, 7–9]. It is mainly a disease of middle-aged
white men and it is suspected that an immunogenetic
susceptibility might be required for developing the late-
onset disease [6]. Our patient is a HLA B27 carrier; an
association of cWD and HLA B27 has been described by
Feurle et al. in 1979 [10].
Whipple’s endocarditis is a frequent chronic extraintes-
tinal manifestation due to T. whipplei infection and it
represents one of the most common causes of BCNE [6].
A high prevalence of Whipple’s disease has been reported
in eastern-central France, Switzerland and Germany. It is
not known if it is due to the high prevalence of the agent
in this area or whether it is a result of a better search for
the disease [11, 12]. Geissdörfer et al. found in a cohort
study in Germany that T. whipplei was the fourth most
frequent pathogen (6.3 %) of 255 cases of bacterial
endocarditis after streptococci, staphylococci and en-
terococci listed as the main pathogens [13]. As it is for
cWD, Whipple’s endocarditis affects mainly white men
in their sixties [8, 11]. The clinical presentation is primar-
ily due to the valvular lesions manifested by acute heart fail-
ure. Arthralgia or arthritis often precedes the diagnosis of
endocarditis as shown by Fenollar et al. in their observa-
tional cohort study of 28 cases of Whipple’s endocarditis. In
this study, 75 % of patients reported previous joint pain
[11]. Fever, however, is described in only 25–30 % of cases
Fig. 4 Histopathology findings: microscopic appearance of T. whipplei-infected native mitral valve specimen. a On low-power view, dense foamy
macrophage infiltrate within the valve (hematoxylin and eosin, original magnification × 200). b On high-power view, macrophages with light gray
and granular cytoplasm (hematoxylin and eosin, original magnification × 400). c The cytoplasm is filled with periodic acid-Schiff-positive material
(original magnification × 200). d The cytoplasmatic periodic acid-Schiff-positive material is also strongly positive with Warthin-Starry stain (original
magnification × 400)
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and gastrointestinal symptoms appeared to be rare [6, 11].
Thus, the Duke criteria that are proposed for the diagnosis
of endocarditis are usually not helpful in this context. Our
patient also presented mainly with cardiovascular symp-
toms and a single episode of fever. Moreover, and typical
for Whipple’s endocarditis, he presented with arthralgia for
2 years, for which no etiology was identified. Interestingly,
the arthralgia disappeared with the antibiotic treatment.
Therefore, arthralgia was an important diagnostic clue in
his medical history and should always be looked for in
BCNE. Previous heart valve disease has been described in
about one third of cases, but was not present in our patient.
Aortic and mitral valves are most frequently involved with
a few reports of tricuspid endocarditis [6, 11, 14].
The diagnosis of Whipple’s endocarditis is mainly con-
firmed by surgically obtained specimens of the involved
cardiac valves. The pathologic features of the valves include
vegetations of different size, significant fibrosis and the
presence of foamy macrophages containing numerous
PAS-positive inclusions with slight inflammation [2, 8, 13].
However, PAS staining is not specific for T. whipplei infec-
tion since PAS-positive macrophages have been found with
other infectious agents [8]. Currently, molecular analysis of
the valves using a specific PCR is the best diagnostic
approach [6, 15]. Although screening of saliva and fecal
specimens by PCR has a high negative predictive value in
diagnosing cWD [6], it is not the case for Whipple’s endo-
carditis. In addition, PCR assays of blood samples showed
a low sensitivity for the disease [6, 11]. On the other hand,
growth of T. whipplei cannot be really considered as a diag-
nostic tool due to the difficulty of the technique and the
very few specialized laboratories available. Improvement of
diagnostic tools is therefore necessary to allow a better
diagnosis of Whipple’s endocarditis before cardiac surgery.
Regarding the treatment of Whipple’s endocarditis,
there is no standard antibiotic strategy and it is generally
based on the therapeutic protocol for cWD. Prior cases
have reported failure of treatment with trimethoprim-
sulfametoxazole in cWD and also in Whipple’s endocar-
ditis [16, 17]. Moreover, trimethoprim is not active on T.
whipplei since its drug target is missing. Thus, some
authors recommend 2 weeks of ceftriaxone followed by
a combination of doxycycline and hydroxychloroquine
with control of drug concentration in the blood every 3
months [8, 11]. The length of the treatment has not
been defined precisely, and an antibiotic course of 18–
24 months is often proposed in the literature. However,
some experts recommend a lifelong treatment consider-
ing that a genetic susceptibility of the host likely plays a
role in relapses and reinfection with another strain [18].
Such a lifelong treatment was prescribed to our patient.
Our patient was informed of the risk of photosensitivity
and retinal toxicity related to doxycycline and hydroxy-
chloroquine, respectively. Rarely, hydroxychloroquine can
induce a toxic cardiomyopathy manifested by, for ex-
ample, severe systolic dysfunction [19]. Follow-up includes
control of the plasma level of antibiotics, blood count and
hepatic and renal function and a regular ophthalmological
control. In addition, PCR on saliva and stools may be done
3 and 6 months after treatment start, and then once a year
to possibly detect early relapse or reinfection.
Conclusions
We report a typically subacute presentation of infective
endocarditis due to T. whipplei with a previous history
of migrant arthralgia of unknown etiology. This case
highlights the importance of looking for unusual fastidi-
ous bacteria in the occurrence of BCNE endocarditis as
soon as blood cultures return with negative results. In-
vestigations should systematically include T. whipplei
given its common occurrence in such settings. Lifelong
antibiotic treatment could be considered to treat T.
whipplei endocarditis even if prospective studies are
lacking.
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